Guidelines for the treatment of chronic spontaneous urticaria (CSU) recommend the use of
the IgE-targeted biologic omalizumab in patients with antihistamine-refractory disease. The …

Chronic urticaria (CU) is a common skin condition characterized by the recurrence of
wheals, with or without angioedema, which lasts for at least 6 weeks. Owing to its pruritus …

Omalizumab is an effective treatment for patients with chronic spontaneous urticaria (CSU).
In routine clinical practice, physicians often face complex cases of CSU and need to decide …

In chronic spontaneous urticaria (CSU), wheals, angioedema, or both appear spontaneously
for> 6 weeks. Current recommended treatment options for urticaria target mast cell …

Background Data on real-life experience with omalizumab dose/interval adjustments are still
limited, as well as on omalizumab discontinuation. Objective To evaluate efficacy and safety …

Introduction Chronic urticaria (CU) appears with daily or intermittent/recurrent wheals
with/without angioedema for more than six weeks. When no specific eliciting factors are …

Background Although there have been significant advances in the treatment of chronic
spontaneous urticaria (CSU) in recent years, there remains a lack of clear guidance on …

Introduction Due to daily hives with itch, sleeplessness, and unforeseen development of
angioedema, chronic spontaneous urticaria significantly impairs quality of life, often for …

Introduction: This study aimed to evaluate factors affecting drug survival and treatment
response in patients with chronic urticaria treated with omalizumab in clinical practice …

Chronic spontaneous urticaria (CsU) is a chronic inflammatory dermatosis whose etiology is
not yet fully understood. In affected patients, it is often associated with a high limitation of …